MELODY EVANS: Open Payments
NPI 1811571110 · OKMULGEE, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$231 in 11 payments from 7 companies in 2025. Trend: 2023 $504 · 2024 $369 · 2025 $231
Food & beverage: $231
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 3 | $75 |
| Novo Nordisk Inc | 3 | $50 |
| Lundbeck LLC | 1 | $29 |
| Lilly USA, LLC | 1 | $21 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $19 |
| GENZYME CORPORATION | 1 | $19 |
| Astellas Pharma US Inc | 1 | $19 |
Products named: REXULTI, Ozempic, JARDIANCE, Kerendia, DUPIXENT, Veozah, Rybelsus.
Industry payments across OK — which companies pay providers there.
